Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Sep;39(9):1769-1779.
doi: 10.1111/jgh.16614. Epub 2024 May 12.

Adverse events in endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stents: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Adverse events in endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stents: A systematic review and meta-analysis

Jia-Su Li et al. J Gastroenterol Hepatol. 2024 Sep.

Abstract

Background and aim: Several meta-analyses have analyzed the technical and clinical success of endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) by using lumen-apposing metal stents (LAMS) in malignant biliary obstruction, but those concerning adverse events (AEs) are scarce. The current systematic review and meta-analysis was conducted to evaluate the AEs after EUS-CDS with LAMS.

Methods: A comprehensive literature search of PubMed, Embase, Scopus, Web of Science, and the Cochrane Library was conducted for studies reporting the outcomes of EUS-CDS with LAMS. The main endpoints were the incidence of overall and specific AEs. Moreover, the stent dysfunction, and reintervention rates were evaluated independently.

Results: A total of 21 studies (n = 1438) were included in the final meta-analysis. The pooled rate of technical and clinical success was 93.5% (95% confidence interval [CI]: 91.3-95.1) and 88.0% (95% CI: 83.9-91.1), respectively. After EUS-CDS with LAMS, the pooled incidence of overall AEs was 20.1% (95% CI: 16.0-24.9). The estimated rate of early AEs was 10.6% (95% CI: 7.9-14.2), and late AEs was 11.2% (95% CI: 8.2-15.2). Infection/cholangitis was the commonest AE, with a pooled incidence of 6.1% (95% CI: 3.7-10.1). The estimated incidence of stent dysfunction and reintervention was 10.5% (95% CI: 7.5-14.4), and 12.1% (95% CI: 9.3-15.7), respectively.

Conclusion: Despite with a high technical and clinical success rate, EUS-CDS with LAMS may be associated with overall AEs and stent dysfunction in one-fifth and one-tenth of cases, respectively. Further efforts are required to optimize its safety and long-term stent patency.

Keywords: Adverse events; Biliary obstruction; Choledochoduodenostomy; Endoscopic ultrasound; Lumen‐apposing metal stent.

PubMed Disclaimer

References

    1. Teoh AYB, Napoleon B, Kunda R et al. EUS‐guided choledocho‐duodenostomy using lumen apposing stent versus ERCP with covered metallic stents in patients with unresectable malignant distal biliary obstruction: a multicenter randomized controlled trial (DRA‐MBO Trial). Gastroenterology 2023; 165: 473–482.
    1. Chen YI, Sahai A, Donatelli G et al. Endoscopic ultrasound‐guided biliary drainage of first intent with a lumen‐apposing metal stent vs. endoscopic retrograde cholangiopancreatography in malignant distal biliary obstruction: a multicenter randomized controlled study (ELEMENT trial). Gastroenterology 2023. https://doi.org/10.1053/j.gastro.2023.07.024.
    1. Ginestet C, Sanglier F, Hummel V et al. EUS‐guided biliary drainage with electrocautery‐enhanced lumen‐apposing metal stent placement should replace PTBD after ERCP failure in patients with distal tumoral biliary obstruction: a large real‐life study. Surg Endosc 2022; 36: 3365–3373.
    1. Mohan BP, Shakhatreh M, Garg R, Ponnada S, Navaneethan U, Adler DG. Efficacy and safety of endoscopic ultrasound‐guided choledochoduodenostomy: a systematic review and meta‐analysis. J Clin Gastroenterol 2019; 53: 243–250.
    1. Krishnamoorthi R, Dasari CS, Thoguluva Chandrasekar V et al. Effectiveness and safety of EUS‐guided choledochoduodenostomy using lumen‐apposing metal stents (LAMS): a systematic review and meta‐analysis. Surg Endosc 2020; 34: 2866–2877.

LinkOut - more resources